Table 1 Effect of zinc, phosphoramidon, and bestatin on plasmatocyte width

a) Mean +/- SD. N = 50 for each test treatment. Range given in brackets. b) 100 µM zinc was also present. 0 µM zinc vs. 100 µM zinc: #1-4 (uneven dashed box) 0 µM zinc vs. 100 µM zinc p < 0.0002 100 µM zinc vs. bestatin or phosphoramidon: #3-6 (even dashed box) Bestatin vs. 100 µM zinc p < 0.0001 Phosphoramidon vs. 100 µM zinc p < 0.0001 Phosphoramidon vs. bestatin p = 0.25 All factors co-analyzed: #3 & #4 (solid line) All factors co-analyzed: #3 & #4 (solid line) 0 µM zinc vs. 100 µM zinc Bestatin vs. 100 µM zinc p < 0.0001 Bestatin vs. 0 µM zinc p = 0.055 Phosphoramidon vs. 100 µM zinc p <.0001 Phosphoramidon vs. 0 µM zinc p = 0.052 Phosphoramidon vs. bestatin p = 0.98 0 µM zinc vs. 100 µM zinc Bestatin vs. 100 µM zinc p < 0.0001 Bestatin vs. 0 µM zinc p = 0.055 Phosphoramidon vs. 100 µM zinc p <.0001 Phosphoramidon vs. 0 µM zinc p = 0.052 Phosphoramidon vs. bestatin p = 0.98